Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Lesueur P, Lequesne J, Grellard JM, Dugué A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D.
Lesueur P, et al. Among authors: berro dh.
BMC Cancer. 2019 Mar 4;19(1):198. doi: 10.1186/s12885-019-5413-y.
BMC Cancer. 2019.
PMID: 30832617
Free PMC article.